| Sodium thiosulfate therapy for calcific uremic arteriolopathy SU Nigwekar, SM Brunelli, D Meade, W Wang, J Hymes, E Lacson Jr Clinical journal of the American Society of Nephrology 8 (7), 1162-1170, 2013 | 260 | 2013 |
| A nationally representative study of calcific uremic arteriolopathy risk factors SU Nigwekar, S Zhao, J Wenger, JL Hymes, FW Maddux, RI Thadhani, ... Journal of the American Society of Nephrology 27 (11), 3421-3429, 2016 | 256 | 2016 |
| Angiotensin in progressive renal diseases: theory and practice. T Matsusaka, J Hymes, I Ichikawa Journal of the American Society of Nephrology 7 (10), 2025-2043, 1996 | 230 | 1996 |
| Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD KE Chan, HS Warren, RI Thadhani, DJR Steele, JL Hymes, FW Maddux, ... Journal of the American Society of Nephrology 23 (9), 1551-1559, 2012 | 76 | 2012 |
| Anaphylaxis and hypotension after administration of peginesatide CL Bennett, S Jacob, J Hymes, LA Usvyat, FW Maddux New England Journal of Medicine 370 (21), 2055-2056, 2014 | 67 | 2014 |
| Dialysis catheter–related bloodstream infections: a cluster-randomized trial of the ClearGuard HD antimicrobial barrier cap JL Hymes, A Mooney, C Van Zandt, L Lynch, R Ziebol, D Killion American Journal of Kidney Diseases 69 (2), 220-227, 2017 | 59 | 2017 |
| Local steroids in dialysis-associated pericardial effusion: a single intrapericardial administration of triamcinolone RJ Quigg, BA Idelson, DC Yoburn, JL Hymes, EC Schick, DB Bernard Archives of internal medicine 145 (12), 2249-2250, 1985 | 30 | 1985 |
| The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis S Sinha, LJ Gould, SU Nigwekar, TE Serena, V Brandenburg, SM Moe, ... Clinical kidney journal 15 (1), 136-144, 2022 | 26 | 2022 |
| Machine learning for prediction of patients on hemodialysis with an undetected SARS-CoV-2 infection CK Monaghan, JW Larkin, S Chaudhuri, H Han, Y Jiao, KM Bermudez, ... Kidney360 2 (3), 456-468, 2021 | 23 | 2021 |
| Lifesaving care for patients with kidney failure during the war in Ukraine 2022 N Stepanova, M Kolesnyk, Z Mithani, B Alkofair, RL Shakour, A Petrova, ... Clinical Journal of the American Society of Nephrology 17 (7), 1079-1081, 2022 | 21 | 2022 |
| Humoral response to mRNA versus an adenovirus vector-based SARS-CoV-2 vaccine in dialysis patients JG Mulhern, A Fadia, R Patel, LH Ficociello, J Willetts, IA Dahne-Steuber, ... Clinical Journal of the American Society of Nephrology 16 (11), 1720-1722, 2021 | 21 | 2021 |
| Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa J Hymes, T Bickimer, JH Jackson, BK Bookhart, SH Mody, CT Piech Current medical research and opinion 23 (8), 1931-1937, 2007 | 16 | 2007 |
| Real-time prediction of intradialytic relative blood volume: a proof-of-concept for integrated cloud computing infrastructure S Chaudhuri, H Han, C Monaghan, J Larkin, P Waguespack, B Shulman, ... BMC nephrology 22 (1), 274, 2021 | 15 | 2021 |
| Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population C Zoccali, G Tripepi, L Neri, M Savoia, ME Baró Salvador, P Ponce, ... Nephrology Dialysis Transplantation 38 (7), 1700-1706, 2023 | 13 | 2023 |
| Associates of cardiopulmonary arrest in the perihemodialytic period JE Flythe, NC Li, SF Lin, SM Brunelli, J Hymes, E Lacson Jr International Journal of Nephrology 2014 (1), 961978, 2014 | 13 | 2014 |
| Assessment of provision of COVID-19 vaccination in dialysis clinics and patient vaccination coverage PR Patel, LJ Tanz, E Hamilton, K Swanzy, JL Hymes, J Giullian, ... JAMA Internal Medicine 182 (6), 676-678, 2022 | 10 | 2022 |
| War in Ukraine and dialysis treatment: human suffering and organizational challenges V Novakivskyy, R Shurduk, I Grin, T Tkachenko, N Pavlenko, A Hrynevych, ... Clinical Kidney Journal 16 (4), 676-683, 2023 | 9 | 2023 |
| Artificial intelligence for covid-19 risk classification in kidney disease: Can technology unmask an unseen disease? C Monaghan, JW Larkin, S Chaudhuri, H Han, Y Jiao, KM Bermudez, ... MedRxiv, 2020.06. 15.20131680, 2020 | 9 | 2020 |
| Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) using a specified dosing algorithm: a randomized, non-inferiority study in adults on hemodialysis R Thadhani, R Guilatco, J Hymes, FW Maddux, A Ahuja American Journal of Nephrology 48 (3), 214-224, 2018 | 9 | 2018 |
| Trajectories of clinical and laboratory characteristics associated with COVID‐19 in hemodialysis patients by survival S Chaudhuri, R Lasky, Y Jiao, J Larkin, C Monaghan, A Winter, L Neri, ... Hemodialysis International 26 (1), 94-107, 2022 | 8 | 2022 |
Franklin W. Maddux, MD, FACPChief Medical Officer and Executive Vice President of Clinical and Scientific Affairs, FreseniusПодтвержден адрес электронной почты в домене fmc-na.com
